Risk factors for perinatal HIV-1 transmission in pregnant women requiring lifelong antiretroviral therapy: A longitudinal study at a tertiary hospital in South Africa

South African Journal of Obstetrics and Gynaecology

Volumn 16, Issue 1, 2010, Pages 6-13

  Bera, Ebrahim ^a,b   Jwacu, Nkosazana ^b   Pauls, Freda ^b   Mancotywa, Thozeka ^b   Ngcelwane, Ndileka ^b   Hlati, Yoliswa ^b  

^a WALTER SISULU UNIVERSITY   (South Africa)

^b Frere Hospital   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; ZIDOVUDINE;

ADULT; ARTICLE; BIRTH WEIGHT; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; INFECTION RISK; LIVE BIRTH; MALE; NEWBORN; POLYMERASE CHAIN REACTION; PREDICTION; PREGNANT WOMAN; PREMATURE LABOR; SINGLE DRUG DOSE; SOUTH AFRICA; TERTIARY HEALTH CARE; TREATMENT DURATION; VERTICAL TRANSMISSION; VIRUS LOAD;

EID: 77950799109     PISSN: 00382329     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Fowler MG, Lampe MA Jamieson DJ, Kourtis AP, Rogers MF. Reducing the risk of mother-to-child human immunodeficiency virus transmission: past successes, current progress and challenges, and future directions. Am J Obstet Gynecol 2007; 197: suppl, S3-S9.
2. Thorne C, Malyuta R, Semenenko I, et al. The mother-to-child HIV transmission epidemic in Europe: evolving in the East and established in the West. European Collaborative Study. AIDS 2006; 20(10): 1419-1427.
3. UNAIDS. Joint United Nations Programme on HIV/AIDS. 2009 AIDS Epidemic Update. Geneva, Switzerland: UNAIDS, 2009.
4. Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002; 29(5): 484-494.
5. Simpson BJ, Shapiro ED, Andiman WA. Reduction in the risk of vertical transmission of HIV-1 associated with treatment of pregnant women with orally administered zidovudine alone. J Acquir Immune Defic Syndr 1997; 14(2): 145-152.
6. Rollins NC, Coovadia HM, Bland RM, et al. Pregnancy outcomes in HIV-Infected and uninfected women in rural and urban South Africa. J Acquir Immune Defic Syndr 2007; 44(3): 321-328.
7. Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 1996; 335(22): 1621-1629.
8. Kuhn L, Steketee RW, Weedon J, et al. Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children. J Infect Dis 1999; 179: 52-58.
9. European Mode of Delivery Collaboration. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomized clinical trial. Lancet 1999; 353: 1035-1039.
10. The International Perinatal HIV Group. Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies. AIDS 2001; 15(3): 357-368.
11. Read JS, Newell ML. Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1. The Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD005479. DOI: 10.1002/14651858. CD005479.
12. de Ruiter A, Mercey D, Anderson J, et al. British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008. HIV Med 2008; 9: 452-502.
13. Royal College of Obstetricians and Gynaecologists. Management of HIV in Pregnancy. Guideline No. 39. London: RCOG, 2004.
14. American College of Obstetricians and Gynecologists. Scheduled cesarean delivery and the prevention of vertical transmission of HIV infection: ACOG committee opinion No. 234 (replaces No. 219). Int J Gynaecol Obstet 2001; 73(3): 279-281.
15. Public Health Service Task Force. Recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. 29 April 2009. http://AIDSinfo.nih.gov (accessed 30 August 2009).
16. Boer K, Nellen JF, Patel D, et al. The AmRo study: pregnancy outcome in HIV-1- infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery. Br J Obstet Gynaecol 2007; 114: 148-155.
17. National Department of Health. National HIV and Syphilis Antenatal Seroprevalence Survey in South Africa 2007. Pretoria: Directorate: Health Systems Research, Research Coordination and Epidemiology, Department of Health, 2008. http://www.doh.gov.za (accessed 20 April 2009).
18. Bera E. Maternal outcomes following introduction of antiretroviral therapy in the public sector: A prospective study at a tertiary hospital in the Eastern Cape. South African Journal of Obstetrics and Gynaecology 2009; 15(1): 26-33.
19. Bera E, McCausland K, Nonkwelo R, Mgudlwa B, Chacko S, Majeke B. Birth defects following exposure to efavirenz-based antiretroviral therapy during pregnancy: a study at a regional South African hospital. AIDS 2010; 24(2): 283-289.
20. van der Merwe K, Chersich MF, Technau K, Umurungi Y, Conradie F, Coovadia A. Integration of antiretroviral treatment within antenatal care in Gauteng Province, South Africa. J Acquir Immune Defic Syndr 2006; 43(5): 577-581.
21. Geddes R, Knight S, Reid S, Giddy J, Esterhuizen T, Roberts C. Prevention of mother-to-child transmission of HIV programme: Low vertical transmission in KwaZulu-Natal, South Africa. S Afr Med J 2008; 98: 458-462.
22. Thorne C, Patel D, Fiore S, Peckham C, Newell ML. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 40: 458-465.
23. Warszawski J, Tubiana R, Le Chenadec J, et al. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS 2008; 22(2): 289-299.
24. Dorenbaum A, Cunningham CK, Gelber RD, et al. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission. A randomized trial. JAMA 2002; 288(2): 189-198.
25. Townsend CL, Cortina-Borja M, Peckham CS, et al. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS 2008; 22: 973-981.
26. Mayaux MJ, Blanche S, Rouzioux C, et al. Maternal factors associated with perinatal HIV-1 transmission: The French cohort study: 7 years of follow-up observation. J Acquir Immune Defic Syndr 1995; 8: 188-194.
27. Neely MN, Benning L, Xu J, et al. Cervical shedding of HIV-1 RNA among women with low levels of viraemia while receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2007; 44(1): 38-42.
28. Tuomala RE, O'Driscoll PT, Bremer JW, et al. Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviralexperienced women. J Infect Dis 2003; 187: 375-384.
29. National Department of Health. Policy and Guidelines for the Implementation of the PMTCT Programme 2008. Pretoria: National Department of Health, 2008. http://www.doh.gov.za (accessed 12 November 2008).
30. Rouzioux C, Costagliola D, Burgard M, et al. Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. Am J Epidemiol 1995; 142(12): 1330-1337.
31. Lallemant M, Jourdain G, Le Coeur S, et al. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. N Engl J Med 2000; 343(14): 982-991.
32. Thorne C, Newell M. European Collaborative Study. Are girls more at risk of intrauterine-acquired HIV infection than boys? AIDS 2004; 18(2): 344-347.
33. Galli L, Puliti D, Chiappini E, et al. Low mother-to-child HIV-1 transmission in boys is independent of type of delivery and antiretroviral prophylaxis. J Acquir Immune Defic Syndr 2005; 40(4): 479-485.
34. Grech V, Vassallo-Agius P, Savona-Ventura C. Secular trends in sex ratios at birth in North America and Europe over the second half of the 20th century. J Epidemiol Community Health 2003; 57: 612-615.